(UroToday.com) In the second Hot Topics session of the Société Internationale D’Urologie (SIU) 2021 annual meeting focused on the role of prostate specific membrane antigen (PSMA) and theranostics in prostate cancer, Dr. Robert Reiter began with a presentation on the role of PSMA-based imaging as a diagnostic tool in the initial staging of patients with prostate cancer.